Vaccine

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company…

4 months ago

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company…

4 months ago

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025

CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated…

4 months ago

DM Clinical Research Forms Inaugural Advisory Board to Accelerate Growth and Innovation

HOUSTON, Oct. 8, 2025 /PRNewswire/ -- DM Clinical Research, a leading multi-therapeutic site network, today announced the formation of its…

4 months ago

Evaxion expands AI-Immunology™ platform with automated vaccine design module

New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior…

4 months ago

Veterinary Software Market worth US$2.14 billion by 2030 with 6.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 7, 2025 /PRNewswire/ -- The global Veterinary Software Market, valued at US$1.44 billion in 2024, stood…

4 months ago

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer…

4 months ago

Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials…

4 months ago

Survey: 75% of Medicare Beneficiaries Say Selecting a Plan Is Confusing

More than a third of Medicare Advantage and Part D plan enrollees are unaware that significant plan changes are expected…

4 months ago